![conference banner](/images/conference-banner.jpeg)
Current Chemical Biology
Title:Meet Our Editorial Board Member
Volume: 11 Issue: 2
Author(s): Angelo Facchiano
Affiliation:
Export Options
About this article
Cite this article as:
Facchiano Angelo , Meet Our Editorial Board Member, Current Chemical Biology 2017; 11 (2) . https://dx.doi.org/10.2174/221279681102170912093624
DOI https://dx.doi.org/10.2174/221279681102170912093624 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
Article Metrics
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metals and Metal Derivatives in Medicine
Mini-Reviews in Medicinal Chemistry Costimulation, Coinhibition and Cancer
Current Cancer Drug Targets Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry The Interplay between Noncoding RNAs and p21 Signaling in Gastrointestinal Cancer: From Tumorigenesis to Metastasis
Current Pharmaceutical Design Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models
Clinical Cancer Drugs Discovery of New Biomarkers of Cancer Using Proteomics Technology
Current Cancer Therapy Reviews The Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients
Current Pharmaceutical Biotechnology Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine
Letters in Drug Design & Discovery Fluorescent Nanotechnology: An Evolution in Optical Sensors
Current Analytical Chemistry Review: Recent Clinical Trials in Epigenetic Therapy
Reviews on Recent Clinical Trials Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
Current Pharmaceutical Design Patent Survey of Resveratrol, Taxol, Podophyllotoxin, Withanolides and Their Derivatives Used in Anticancer Therapy
Recent Patents on Biotechnology MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Oncotargets in Different Renal Cancer Subtypes
Current Drug Targets Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia
Current Pharmaceutical Design Folate-Linked Lipid-Based Nanoparticle for Targeted Gene Delivery
Current Drug Delivery The Genomics of Colorectal Cancer: State of the Art
Current Genomics Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis
Current Signal Transduction Therapy Human Galectin-3 Selective and High Affinity Inhibitors. Present State and Future Perspectives
Current Medicinal Chemistry CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
Current Pharmaceutical Design